Publications by authors named "Fangling Ning"

Claim this Profile
N
Novel CDK2/4/6 inhibitor culmerciclib (TQB3616) plus fulvestrant in previously treated, HR-positive, HER2-negative advanced breast cancer: a randomized, double-blind, phase 3 trial.
Yongmei Yin, Qingyuan Zhang, Tao Sun, Chunfang Hao, Zhihong Wang, Fangling Ning

Signal Transduct Target Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
lncRNA IGFL2-AS1 mediates NSCLC chemoresistance via YBX1-induced HSPA1A/RAP1 activation.
Hongliang Dong, Yunxiu Xia, Jingjing Qi, Cuilan Liu, Fei Wang, Fangling Ning

Cell Mol Biol Lett· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel nanoparticle-combined therapy through EGFR and PD-L1 blockade: PFPR-siRNA-mediated suppressing NSCLC proliferation via PDT and enhanced antitumor immunity.
Meiling Zhang, Ning Xie, Dongyang Wu, Chunxia Wu, Yang Guo, Fangling Ning

Colloids Surf B Biointerfaces· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anbenitamab in combination with chemotherapy in patients with HER2-positive gastric or gastroesophageal junction carcinoma who failed previous therapy containing trastuzumab: a multicenter, phase II study (KC-WISE 01).
Chuanhua Zhao, Jun Zhao, Yigui Chen, Bo Liu, Yangfeng Du, Fangling Ning

Cancer Commun (Lond)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line therapy of osimertinib with chemotherapy in Chinese patients with EGFR mutation-positive non-small cell lung cancer: protocol for a multicenter, prospective, observational study.
Bo Zhang, Fangling Ning, Xiaomei Liu, Na Li, Pingfei Wang

Front Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-Line Camrelizumab Versus Placebo Plus Chemotherapy With or Without Radiotherapy for Brain Metastases in NSCLC: The CTONG 2003 Randomized Placebo-Controlled Trial.
Yang-Si Li, Qitao Yu, Qing Bu, Lizhu Lin, Fangling Ning

J Thorac Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small cell lung cancer with EML4-ALK fusion: report of a case responding to ALK TKI and literature review.
Mingyue Wang, Hongzhi Liu, Ruixin Zhang, Runyu Li, Xiaoyu Qin, Fangling Ning

J Cancer Res Clin Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TIFA enhances glycolysis through E2F1 and promotes the progression of glioma.
Zhibing Liu, Miaolong He, Zeshun Yu, Longbo Ma, Xiuwen Wang, Fangling Ning

Cell Signal· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Mechanism of Combining Radiotherapy and Immunotherapy in Stage IV Non-Small Cell Lung Cancer.
Mingyue Wang, Shuo Li, Runyu Li, Fangling Ning, Lijun Tian

Curr Treat Options Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-omics analysis and experiments uncover the function of cancer stemness in ovarian cancer and establish a machine learning-based model for predicting immunotherapy responses.
Zhibing Liu, Lei Han, Xiaoyu Ji, Xiaole Wang, Jinbo Jian, Fangling Ning

Front Immunol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy combined with antiangiogenic therapy as third- or further-line therapy for stage IV non-small cell lung cancer patients with ECOG performance status 2: A retrospective study.
Shuo Li, Ze-Shun Yu, Hong-Zhi Liu, Shu-Jing Li, Ming-Yue Wang, Fang-Ling Ning

Cancer Med· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amelioration of Acute Radiation Dermatitis in Breast Cancer Patients by a Bioadhesive Barrier-Forming Gel (Episil): A Single-Center, Open, Parallel, Randomized, Phase I/II Controlled Trial.
Qian Li, Shanhui Feng, Zeshun Yu, Yue Wang, Lijun Tian, Fangling Ning

Clin Pharmacol Ther· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-cell RNA sequencing reveals tumor heterogeneity, microenvironment, and drug-resistance mechanisms of recurrent glioblastoma.
Haibin Wu, Chengcheng Guo, Chaoye Wang, Jiang Xu, Suyue Zheng, Fangling Ning

Cancer Sci· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DARS-AS1 modulates cell proliferation and migration of gastric cancer cells by regulating miR-330-3p/NAT10 axis.
Chunjuan Du, Xia Han, Yanyan Zhang, Fengli Guo, Haibin Yuan, Fangling Ning

Open Med (Wars)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The "Hand as Foot" teaching method in lymph-node staging of breast cancer.
Xiaole Wang, Fangling Ning, Zhenbo Wang, Miaolong He

Asian J Surg· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of DCE-MRI and DWI in Predicting the Treatment Effect of Concurrent Chemoradiotherapy in Esophageal Carcinoma.
Changmin Liu, Roger Sun, Jing Wang, Fangling Ning, Zhenbo Wang

Biomed Res Int· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of MiR-210 on proliferation, apoptosis and invasion abilities of esophageal cancer cells.
Zhiwen Cheng, Haitao Geng, Yufeng Cheng, Ningxia Dong, Fangling Ning

J BUON· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
APJ Is Associated with Treatment Response in Gastric Cancer Patients Receiving Concurrent Chemoradiotherapy and Endostar Therapy.
Yan-Zhang Hao, Mian-Li Li, Fang-Ling Ning, Xiu-Wen Wang

Cancer Biother Radiopharm· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Silencing of long non-coding RNA ANRIL inhibits the development of multidrug resistance in gastric cancer cells.
Wei-Guang Lan, Dian-Hong Xu, Chen Xu, Chang-Ling Ding, Fang-Ling Ning

Oncol Rep· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medulloblastoma with soft-tissue and skeletal metastases in an adult: A case report.
Dianzhong Geng, Xiaohua Song, Jing Liu, Zeshun Yu, Fangling Ning

Oncol Lett· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Treating Radiation Peumonitis by Zlyin Huoxue Granule Combined Glucocorticoids and Antibiotics: a Clinical Observation].
Li-hua Liu, Shao-shui Chen, Fang-ling Ning

Zhongguo Zhong Xi Yi Jie He Za Zhi· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation dose is associated with prognosis of small cell lung cancer with superior vena cava syndrome.
Zhen-Bo Wang, Fang-Ling Ning, Xiao-Le Wang, Yu-Feng Cheng, Xin-Jun Dong

Int J Clin Exp Med· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MiR-34a Inhibits Viability and Invasion of Human Papillomavirus-Positive Cervical Cancer Cells by Targeting E2F3 and Regulating Survivin.
Dianzhong Geng, Xiaohua Song, Fangling Ning, Qianhua Song, Honghua Yin

Int J Gynecol Cancer· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Gefitinib versus VMP in the combination with radiotherapy for multiple brain metastases from non-small cell lung cancer.
Feng Wang, Fangling Ning, Changmin Liu, Yanzhang Hao, LiMian Li

Cell Biochem Biophys· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II trial of post-operative chemoradiotherapy for completely resected gastric cancer with D2 lymphadenectomy.
Yu-Jie Zhai, Yi-Peng Su, Sheng-Jie Wang, Fang-Ling Ning, Zhen-Bo Wang

Oncol Lett· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis